Baker Bros. Advisors Adds $33M in COMPASS Pathways plc ($CMPS)
Key Points
- $CMPS last traded around $14.15.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Baker Bros. Advisors acquired a new position in COMPASS Pathways plc ($CMPS), according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,344,720 shares of COMPASS Pathways plc. Baker Bros. Advisors's holdings in COMPASS Pathways plc were worth $33.18 million as of its most recent filing.
COMPASS Pathways plc Stock Up 3.1%
Shares of COMPASS Pathways plc ($CMPS) traded around $14.15 on Sunday, up 3.1% for the day.
COMPASS Pathways plc Earnings
Analysts Set New Price Targets
About COMPASS Pathways plc
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Get COMPASS Pathways plc alerts
New 13F filings, insider trades, and analyst moves on $CMPS, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.